Invention Grant
- Patent Title: Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II
-
Application No.: US15603280Application Date: 2017-05-23
-
Publication No.: US09771359B1Publication Date: 2017-09-26
- Inventor: Robert Frank-Foltyn , Christopher Habermann , Gregor Bahrenberg , Bernhard Lesch , Nils Damann , Klaus Schiene , Hannelore Stockhausen , Thomas Christoph , Sven Frormann , Derek Saunders , Jeewoo Lee
- Applicant: MEDIFRON DBT INC.
- Applicant Address: KR Seoul
- Assignee: Medifron DBT Inc.
- Current Assignee: Medifron DBT Inc.
- Current Assignee Address: KR Seoul
- Agency: Lathrop & Gage LLP
- Priority: EP14003949 20141124
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D277/28 ; C07D263/32 ; C07D413/12 ; C07D417/12 ; C07D413/14 ; A61K31/4439 ; A61K31/421 ; A61K31/426 ; A61K31/506
Abstract:
The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Public/Granted literature
Information query
